This inventor holds 2 USPTO granted patents. Top assignee: Dracen Pharmaceuticals, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Steven Dykstra
Introduction
Steven Dykstra is an accomplished inventor based in Apex, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. His work focuses on enhancing the efficacy of drug delivery systems.
Latest Patents
Dykstra holds a patent for a lyophilized composition comprising (S)-isopropyl 2-((S)-2-acetamido-3-(1H-indol-3-yl)propanamido)-6-diazo-5-oxohexanoate for subcutaneous administration. This patent outlines the formulation and use of lyophilates that can be administered subcutaneously to subjects, providing a novel approach to pharmaceutical compositions and formulations.
Career Highlights
Throughout his career, Dykstra has been associated with Dracen Pharmaceuticals, Inc., where he has played a pivotal role in advancing pharmaceutical innovations. His expertise in drug formulation has contributed to the development of effective therapeutic solutions.
Collaborations
Dykstra has collaborated with notable colleagues, including Gary Elliot and Thomas M Estok. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.
Conclusion
Steven Dykstra's contributions to pharmaceutical innovations exemplify the impact of dedicated inventors in advancing medical science. His work continues to influence the development of effective drug delivery systems, showcasing the importance of innovation in healthcare.